DERMATOPHAGOIDES PTERONYSSINUS ALLERGEN EXTRACT (Acarizax®)

Clinical Indication

Immunotherapy treatment for house dust mite and allergic rhinitis in paediatrics.

Comments

SCA link

Date of classification

December 2022

Orange

Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.